In addition to its clinical mission, the ALS Center has an important research and education mission.
Basic, translational, clinical, and epidemiological research projects are being undertaken by a collaborative team of investigators. Every day clinicians, scientists, students, and patients are working to unravel the complexities of ALS and discover and test new therapies to treat it. This interdisciplinary and comprehensive approach is necessary to tackle challenging neurodegenerative diseases like ALS. The ALS Center collaborates with researchers at Dartmouth College and across the world to improve care for ALS patients.
Clinical trials
Participation in clinical research trials is critical to finding a cure for ALS. Many of the treatment that patients receive today were developed based on the results of previous clinical trials.
We have multiple clinical trials that give people opportunities to help physicians and scientists learn more about ALS and improve treatments for people living with the disease.
There are two main types of clinical trials you may be able to participate in:
- Observational studies: These studies help us understand ALS better and may result in improvements in our ability to diagnose ALS, understand its causes, or uncover new therapeutic targets.
- Interventional trials: These are designed to test the effect of an intervention such as an experimental medication to understand its potential as a treatment for ALS. In many of these trials, participants may be given either an experimental treatment or a control.
View the list of neurology and neuromuscular clinical trials for a full list of clinical trials for ALS and related diseases currently offered at Dartmouth Health. Consider joining a trial today. You could help change the future of medicine.